Trials / Unknown
UnknownNCT05107830
Phenotyping of Primary Hyperoxaluria
Phenotyping of Primary Hyperoxaluria in Children and Adults
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 186 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- —
Summary
985 / 5000 Résultats de traduction Primary hyperoxaluria is a rare autosomal recessive disease with an estimated prevalence of around 1 to 3 cases per million population. The most frequent attacks are urolithiasis disease and nephrocalcinosis, ultimately leading to end-stage chronic renal failure. The phenotype of this pathology is very heterogeneous, making the diagnosis difficult. There is currently a significant diagnostic delay. This is potentially due to atypical forms, or to insufficient clinicians' awareness of its research. However, the early diagnosis of this pathology is essential, since end-stage chronic renal failure can be avoided or at least delayed with early and appropriate management. The objective of the study is to describe the phenotype of currently diagnosed primary hyperoxaluria, in order to identify the classic presentations but also the characteristics of atypical presentations
Conditions
Timeline
- Start date
- 2021-01-22
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2021-11-04
- Last updated
- 2021-11-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05107830. Inclusion in this directory is not an endorsement.